Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-06-19 08:22 Tx date 2025-06-18 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$495.00
+100 vol $4.95 each |
700 | |
Filed 2025-06-19 08:21 Tx date 2025-06-18 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,982
+600 vol $4.97 each |
600 | |
Filed 2025-06-19 08:21 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2025-03-19 12:21 Tx date 2025-03-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,150
+15,000 vol $4.01 each |
69,390 | |
Filed 2024-05-15 11:33 Tx date 2024-05-13 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,100
+15,000 vol $3.94 each |
54,390 | |
Filed 2023-08-23 13:00 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,000
+20,000 vol $4.70 each |
39,390 | |
Filed 2022-12-16 09:38 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
1,583 | ||
Filed 2022-12-15 15:25 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-12-15 15:26 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$31,670
+3,167 vol $10.00 each |
7,250 | |
Filed 2022-12-15 15:25 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
4,083 | ||
Filed 2022-12-15 15:20 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,019
+6,423 vol $10.59 each |
19,390 | |
Filed 2022-06-22 11:51 Tx date 2022-06-17 |
$HLS
HLS Therapeutics Inc. |
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,967 |